Health
Pharmaceutical companies facing a steep patent cliff are concluding the key to future profits may be customized treatments tailored to patients' genes and lifestyles — not blockbusters aimed at large patient populations.
News ID: 1134 Publish Date : 2026/11/03
DRUG
There are troubling new signs that the overhaul of Medicare drug coverage in the Inflation Reduction Act is dramatically driving up program spending.
News ID: 1003 Publish Date : 2026/09/09